The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dalpiciclib combined with chidamide and letrozole as neoadjuvant therapy for HR-positive, HER2-negative early or locally advanced breast cancer: A single-arm, prospective, exploratory clinical study.
 
Yuan Shi
No Relationships to Disclose
 
Baozhong Li
No Relationships to Disclose
 
Caigang Liu
No Relationships to Disclose
 
Haiquan Jia
No Relationships to Disclose
 
Nan Niu
No Relationships to Disclose
 
Xianhua Qiu
No Relationships to Disclose
 
Jianyun Guan
No Relationships to Disclose
 
Lisha Sun
No Relationships to Disclose
 
Guanglei Chen
No Relationships to Disclose
 
Jiacai Liu
No Relationships to Disclose
 
Fuqiang Wang
No Relationships to Disclose
 
Nan Xu
No Relationships to Disclose